Trial Profile
To compare real world treatment patterns and inpatient utilisation between schizophrenia patients stabilized on treatment with once monthly versus twice monthly long acting injectable antipsychotics
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2017
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Paliperidone (Primary) ; Risperidone
- Indications Schizophrenia
- Focus Therapeutic Use
- 21 Sep 2017 New trial record
- 30 Aug 2017 Results presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management